Live Terminal | Security Analysis of 005690.KS
TERMINAL beta
Version: 0.1
Timestamp: 1708727630.171248
Options
100220.KS
52.83%
1809.TW
51.88%
006220.KS
49.51%
0756.HK
49.35%
B7J.DE
48.43%
0T8B.F
-39.43%
009310.KS
-40.63%
SZGPF
-42.69%
GOLL4.SA
-52.40%
HGEN.L
-53.56%
AAPL $182.88 -0.81%
AMD $176.41 -3.00%
AMZN $174.58 0.00%
BRK-B $417.87 0.65%
GOOG $145.44 0.08%
IBM $185.76 0.84%
INTC $43.28 0.71%
JNJ $161.87 0.89%
JPM $184.12 0.57%
META $488.06 0.40%
MSFT $410.31 -0.33%
O $53.27 0.85%
TSLA $195.04 -1.20%
WMT $176.24 0.47%
QQQ $437.06 -0.2306%
TLT $93.88 1.3441%
VUAA.DE $88.65 0.3918%
VUSA.DE $89.31 0.4025%
FJPR.L $5.64 1.5565%
VWRP.L $97.83 0.1638%
VWRL.L $98.54 0.1626%
EMGU.L $3.60 -0.1111%
RDVY $52.46 0.4211%
FLOT $50.99 0.0098%
SCHZ $45.73 0.3952%
IBB $138.22 0.7655%
C020.DE $21.34 0.0000%
DFAX $24.72 0.0862%
MEUD.PA $226.19 0.4173%
LYP6.DE $226.20 0.4440%
IDWR.L $71.10 0.4521%
IQQW.DE $65.72 0.3972%
EXS1.DE $145.70 0.2477%
XESC.L $6865.00 0.1240%
DFAU $35.28 0.1783%
ACWV $104.09 0.3277%
VHYD.L $63.92 0.2746%
VGWD.DE $59.24 0.5602%
FXKZ.ME $303.00 0.0000%

Latest articles

No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.

Sentiment statistics ?
005690.KS
μ null
null
null

Financial Histories

Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.

Overview
005690.KS
Latest Performance
005690.KS$5680.00
$-10.00 • -0.18%
005690.KS
Price 5680.00
Change Pct -0.18
Change Abs -10.00
Market Cap 340.8 billion
Eps 0.00
Pe Ratio null
Outstanding Shares 60.0 million
Volume 264684
Avg Volume 415363
Industry Biotechnology
Sector Name Health Care
Country Short Name KR
Announcement Earnings 2024-05-13 10:59:00+00:00
All metrics in USD or %.
Dividends

There is no dividend data to display. Refer our Dividend calendar for other accurate data.

Risk Profiles

Please sign up and become a member to view all risk profiles.

Competitors/Peer Groups
005690.KS
Same Country:
Same Decade:
Intraday: +2.27%
Focus

The 'Focus' Area is meant to be an One-Pager about all Important Insights, Risks and Opportunities to solely analyze a single corporate.

Company descriptions
005690.KS

Pharmicell Co., Ltd., a biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally. The company operates in Biopharmaceutical Business and Biochemical Business divisions. It offers Cellgram_AMI that is manufactured using autologous bone marrow-derived mesenchymal stem cell to enhance the ejection fraction in patients with acute myocardial infarction reperfused by coronary angioplasty. The company's products under development include Cellgram_LC, a liver disease drug;